BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sahlin M, Bauden MP, Andersson R, Ansari D. Radioimmunotherapy--a potential novel tool for pancreatic cancer therapy? Tumour Biol 2015;36:4053-62. [PMID: 25926382 DOI: 10.1007/s13277-015-3479-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Uccelli L, Martini P, Pasquali M, Boschi A. Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy. Biomed Res Int 2017;2017:5923609. [PMID: 28951872 DOI: 10.1155/2017/5923609] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
2 Jiao R, Allen KJH, Malo ME, Helal M, Jiang Z, Smart K, Buhl SV, Rickles D, Bryan RA, Dadachova E. Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer. Cancer Med 2019;8:5289-300. [PMID: 31309741 DOI: 10.1002/cam4.2379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Matta-Domjan B, King A, Totti S, Matta C, Dover G, Martinez P, Zakhidov A, La Ragione R, Macedo H, Jurewicz I, Dalton A, Velliou EG. Biophysical interactions between pancreatic cancer cells and pristine carbon nanotube substrates: Potential application for pancreatic cancer tissue engineering. J Biomed Mater Res B Appl Biomater 2018;106:1637-44. [PMID: 28976640 DOI: 10.1002/jbm.b.34012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
4 Kasten BB, Ferrone S, Zinn KR, Buchsbaum DJ. B7-H3-targeted Radioimmunotherapy of Human Cancer. Curr Med Chem 2020;27:4016-38. [PMID: 30836909 DOI: 10.2174/0929867326666190228120908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Kasten BB, Gangrade A, Kim H, Fan J, Ferrone S, Ferrone CR, Zinn KR, Buchsbaum DJ. 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models. Nucl Med Biol 2018;58:67-73. [PMID: 29413459 DOI: 10.1016/j.nucmedbio.2017.12.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
6 Xiao J, Xu X, Li X, Li Y, Liu G, Tan H, Shen H, Shi H, Cheng D. Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer. Molecules 2016;21:E1308. [PMID: 27706035 DOI: 10.3390/molecules21101308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fan JQ, Wang MF, Chen HL, Shang D, Das JK, Song J. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma. Mol Cancer 2020;19:32. [PMID: 32061257 DOI: 10.1186/s12943-020-01151-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 10.5] [Reference Citation Analysis]
8 Sabanathan D, Lund ME, Campbell DH, Walsh BJ, Gurney H. Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target. Ther Adv Med Oncol 2021;13:17588359211022918. [PMID: 34646364 DOI: 10.1177/17588359211022918] [Reference Citation Analysis]